{
  "meta": {
    "title": "18_Zoonotic_Infections_-_Viral",
    "url": "https://brainandscalpel.vercel.app/18-zoonotic-infections-viral-418b07d6.html",
    "scrapedAt": "2025-11-30T12:26:55.199Z"
  },
  "questions": [
    {
      "text": "A man is referred for fever and agitation for the past 4 days. Examination reveals a disoriented man who is unable to swallow water due to involuntary inspiratory muscle spasms of the pharynx.  He had been bitten by a dog 3 months ago but was not treated. What genus does the causative organism of this condition belong to?",
      "choices": [
        {
          "id": 1,
          "text": "Flavivirus"
        },
        {
          "id": 2,
          "text": "Lyssavirus"
        },
        {
          "id": 3,
          "text": "Rubivirus"
        },
        {
          "id": 4,
          "text": "Rhabdovirus"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>This clinical scenario with <strong>hydrophobia</strong> and a history of an untreated dog bite is highly suggestive of <strong>rabies</strong>.&nbsp;The causative virus belongs to the genus&nbsp;<em><strong>Lyssavirus</strong></em>.<strong>&nbsp;</strong>&nbsp;</p>\n<p><strong>Rabies virus</strong>&nbsp;is an RNA virus that belongs to the <strong>family</strong> <strong>Rhabdoviridae</strong>. This family has&nbsp;3 genera:</p>\n<ul>\n<li aria-level=\"1\">Lyssavirus</li>\n<li aria-level=\"1\">Vesiculovirus</li>\n<li aria-level=\"1\">Ephemerovirus</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB8300",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is false about the fixed virus of rabies?",
      "choices": [
        {
          "id": 1,
          "text": "Has a long incubation period"
        },
        {
          "id": 2,
          "text": "Not form Negri bodies"
        },
        {
          "id": 3,
          "text": "Does not multiply in extra neural tissues"
        },
        {
          "id": 4,
          "text": "Used in vaccine preparation"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The <strong>fixed</strong> virus has a <strong>short</strong> <strong>incubation</strong> period.</p>\n<p>There are 2 types of rabies viruses:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Fixed virus</strong></td>\n<td><strong>Street virus&nbsp;</strong></td>\n</tr>\n<tr>\n<td>\n<p>Isolated after several intracerebral passages in rabbits</p>\n</td>\n<td>\n<p>Isolated from naturally&nbsp;occurring cases of rabies</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Short, fixed, and reproducible incubation period of 6 to 7 days</p>\n</td>\n<td>The incubation period is long<strong>&nbsp;</strong>and&nbsp;highly variable between 1 to 12 weeks</td>\n</tr>\n<tr>\n<td>\n<p>Does not form Negri bodies or multiply in extraneural tissues</p>\n</td>\n<td>Forms Negri bodies and multiplies in extraneural tissues</td>\n</tr>\n<tr>\n<td>\n<p>Used in the preparation of live-attenuated&nbsp;<strong>anti-rabies vaccine</strong></p>\n</td>\n<td>It is the primary cause of rabies disease</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB8301",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following does not lead to the transmission of rabies to humans?",
      "choices": [
        {
          "id": 1,
          "text": "Nibbling by an infected animal on abraded skin"
        },
        {
          "id": 2,
          "text": "Bite of an infected bat"
        },
        {
          "id": 3,
          "text": "Direct contact of infected saliva with the mucosa"
        },
        {
          "id": 4,
          "text": "Ingestion of raw meat of infected animal"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Ingestion of the raw meat of the infected animal does not lead to the transmission of rabies.</p>\n<p>Mammals like dogs and bats are important animal sources. The important modes of transmission of rabies are as follows:</p>\n<ul>\n<li>Scratches<strong>&nbsp;</strong>or<strong>&nbsp;</strong>deep bites</li>\n<li>Exposure of infected saliva to intact mucosa or fresh skin wounds</li>\n</ul>\n<p>Human&ndash;to&ndash;human transmission through bites has&nbsp;never been confirmed.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB8302",
      "difficulty": "easy"
    },
    {
      "text": "You have witnessed your neighbor being bitten by a rabid dog. You should advise him to wash the wound with soap and water for a minimum of:",
      "choices": [
        {
          "id": 1,
          "text": "25 minutes"
        },
        {
          "id": 2,
          "text": "5 minutes"
        },
        {
          "id": 3,
          "text": "10 minutes"
        },
        {
          "id": 4,
          "text": "15 minutes"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Following dog bites, the <strong>bite wound</strong>&nbsp;should be <strong>washed</strong> with soap under running tap water for <strong>15 minutes</strong>.</p>\n<p>Local treatment of the bite wound is essential for the prevention of rabies and can reduce the infection rate by up to 80%. The following steps must be followed:</p>\n<ul>\n<li><strong>Cleansing</strong>:&nbsp;Washing under running water with soap or irrigation with a catheter in case of deep wounds</li>\n<li><strong>Chemical agent</strong>: Alcohol or tincture /0.01% aqueous solution of iodine or povidone-iodine is effective for <strong>inactivation</strong> of <strong>residual</strong> <strong>virus</strong></li>\n<li><strong>Suturing: </strong>Must be done only <strong>following 24-48 hours</strong> if necessary, under the&nbsp;cover of rabies immunoglobulin locally and minimal stitches</li>\n<li><strong>Antibiotics </strong>and<strong> anti-tetanus </strong>measures&nbsp;when indicated</li>\n</ul><hr><h3>Related Pearl: Rabies vaccines and immunoglobulins schedules</h3><p>According to the Ministry of Health and Family Welfare, Government of India:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f49dfa01d9bd424db725e4ebf600cb98x1280x3397.JPEG\" alt=\"Pearl Image\"><p>WHO category <strong>II</strong> or <strong>III</strong> exposures should receive&nbsp;<strong>post-exposure prophylaxis&nbsp;</strong>(PEP)<strong>&nbsp;immediately.</strong></p>\n<p>One <strong>intradermal&nbsp;</strong>(ID)&nbsp;dose is <strong>0.1 mL</strong> of vaccine and one <strong>intramuscular</strong> (IM) dose is an <strong>entire vial</strong> of vaccine, irrespective of the vial size.</p>\n<p>Should a vaccine dose be delayed for any reason, the PEP schedule should be resumed (not restarted).</p>\n<p><strong>Rabies Immunoglobulin(RIG):&nbsp;</strong></p>\n<ul>\n<li>Passive immunization</li>\n<li><strong>Single-dose</strong>; after initiation of PEP and not beyond 7 days after the first dose of vaccine</li>\n<li>Max dose: <strong>hRIG - 20IU/kg ,&nbsp;</strong><strong>eRIG</strong><strong>&nbsp;- 40IU/kg </strong>body weight</li>\n<li>Vaccines should never be withheld regardless of the availability of RIG.</li>\n<li><strong>Alternatives</strong> for RIG- WHO recommends&nbsp;<strong>m</strong><strong>onoclonal antibodies&nbsp;</strong>(mAb)&nbsp;as a 'cocktail' containing at least <strong>two antibodies</strong> against the rabies virus.</li>\n</ul>\n<p>Administration of RIG:</p>\n<ul>\n<li>RIG should be administered&nbsp;<strong>into</strong> or <strong>around</strong> the <strong>wound site</strong> or sites.</li>\n<li>The&nbsp;<strong>remaining</strong> RIG, if any, should be injected <strong>IM</strong> at a site <strong>distant</strong> from the <strong>site</strong> of vaccine administration.</li>\n<li>RIG may be diluted to a volume sufficient for all wounds to be effectively and safely infiltrated.</li>\n</ul>\n<p>Prioritization&nbsp;of RIG allocation (numbered according to priority order):</p>\n<ol>\n<li>Multiple bites</li>\n<li>Deep wounds</li>\n<li>Bites to head, neck, and hands</li>\n<li>Patients with severe immunodeficiency</li>\n<li>Confirmed/probable rabies in biting animal</li>\n<li>Bites, scratches, and exposure of mucous membranes caused by a bat</li>\n</ol>\n<p><strong>Pre-exposure prophylaxis&nbsp;(PrEP)</strong></p>\n<p>PrEP is considered in the following conditions:</p>\n<ul>\n<li>High-risk groups- laboratory staff, wildlife wardens, veterinarians, animal handlers, and travelers to endemic regions.</li>\n<li>Remote, rabies-endemic areas where access to PEP is difficult</li>\n<li>Areas where&nbsp;dog bite incidence is &gt;5% per year</li>\n<li>Areas where vampire bat rabies is known to be present.</li>\n</ul>\n<p>Pre-exposure rabies vaccination consists of <strong>3&nbsp;intramuscular (IM) or 3 intradermal (ID)</strong>&nbsp;doses. These are given on <strong>days 0, 7 and 21 or 28.</strong></p>\n<ul>\n<li>Adults - the vaccine should always be administered in the deltoid area of the arm</li>\n<li>Young children (under 1 year of age)- Administration into the anterolateral area of the thigh is recommended.</li>\n<li><strong>Rabies vaccine </strong>should<strong> never</strong> be administered in the<strong> gluteal area.</strong>&nbsp;Administration in this manner will result in <strong>lower neutralizing antibody titers.</strong></li>\n</ul>\n<p>For exposed or re-exposed patients who can document previous completion of PEP or PrEP the following guidelines would be applicable:</p>\n<ul>\n<li>Proper wound management should be done.</li>\n<li>There is no need for the administration of RIG.</li>\n<li>One site ID or IM vaccine administration on days 0 and 3.</li>\n</ul>\n<p>Only adequate wound washing would be required in case of re-exposure where the animal bite victim has documented proof of complete PEP&nbsp;<strong>within the last three months.</strong></p>\n<p>The following cases are treated as fresh cases and given full PEP:</p>\n<ul>\n<li>Those who have previously received full post-exposure treatment with neural tissue vaccines (NTV) or vaccines of unproven potency</li>\n<li>Those who cannot document complete PEP or PrEP treatment&nbsp;</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB8303",
      "difficulty": "medium"
    },
    {
      "text": "A worker at a veterinary hospital has just received the 1st dose of rabies vaccine as a pre-exposure prophylactic measure. When should he return for the remaining doses?",
      "choices": [
        {
          "id": 1,
          "text": "On day 3 only"
        },
        {
          "id": 2,
          "text": "On days 3, 7, 28"
        },
        {
          "id": 3,
          "text": "On days 3, 7, 14, 28"
        },
        {
          "id": 4,
          "text": "On days 7, 21"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Pre-exposure prophylaxis</strong> for rabies consists of 3 doses to be given on <strong>days</strong> <strong> 0, 7, </strong>and<strong> 21 or 28.</strong>&nbsp;They are given&nbsp;intramuscularly<strong>&nbsp;</strong>or intradermally&nbsp;in the deltoid area of the arm.&nbsp;</p>\n<p>High-risk groups like laboratory staff, wildlife wardens, veterinarians, animal handlers, and travelers to endemic regions are candidates for pre-exposure prophylaxis.</p><hr><h3>Related Pearl: Rabies vaccines and immunoglobulins schedules</h3><p>According to the Ministry of Health and Family Welfare, Government of India:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f49dfa01d9bd424db725e4ebf600cb98x1280x3397.JPEG\" alt=\"Pearl Image\"><p>WHO category <strong>II</strong> or <strong>III</strong> exposures should receive&nbsp;<strong>post-exposure prophylaxis&nbsp;</strong>(PEP)<strong>&nbsp;immediately.</strong></p>\n<p>One <strong>intradermal&nbsp;</strong>(ID)&nbsp;dose is <strong>0.1 mL</strong> of vaccine and one <strong>intramuscular</strong> (IM) dose is an <strong>entire vial</strong> of vaccine, irrespective of the vial size.</p>\n<p>Should a vaccine dose be delayed for any reason, the PEP schedule should be resumed (not restarted).</p>\n<p><strong>Rabies Immunoglobulin(RIG):&nbsp;</strong></p>\n<ul>\n<li>Passive immunization</li>\n<li><strong>Single-dose</strong>; after initiation of PEP and not beyond 7 days after the first dose of vaccine</li>\n<li>Max dose: <strong>hRIG - 20IU/kg ,&nbsp;</strong><strong>eRIG</strong><strong>&nbsp;- 40IU/kg </strong>body weight</li>\n<li>Vaccines should never be withheld regardless of the availability of RIG.</li>\n<li><strong>Alternatives</strong> for RIG- WHO recommends&nbsp;<strong>m</strong><strong>onoclonal antibodies&nbsp;</strong>(mAb)&nbsp;as a 'cocktail' containing at least <strong>two antibodies</strong> against the rabies virus.</li>\n</ul>\n<p>Administration of RIG:</p>\n<ul>\n<li>RIG should be administered&nbsp;<strong>into</strong> or <strong>around</strong> the <strong>wound site</strong> or sites.</li>\n<li>The&nbsp;<strong>remaining</strong> RIG, if any, should be injected <strong>IM</strong> at a site <strong>distant</strong> from the <strong>site</strong> of vaccine administration.</li>\n<li>RIG may be diluted to a volume sufficient for all wounds to be effectively and safely infiltrated.</li>\n</ul>\n<p>Prioritization&nbsp;of RIG allocation (numbered according to priority order):</p>\n<ol>\n<li>Multiple bites</li>\n<li>Deep wounds</li>\n<li>Bites to head, neck, and hands</li>\n<li>Patients with severe immunodeficiency</li>\n<li>Confirmed/probable rabies in biting animal</li>\n<li>Bites, scratches, and exposure of mucous membranes caused by a bat</li>\n</ol>\n<p><strong>Pre-exposure prophylaxis&nbsp;(PrEP)</strong></p>\n<p>PrEP is considered in the following conditions:</p>\n<ul>\n<li>High-risk groups- laboratory staff, wildlife wardens, veterinarians, animal handlers, and travelers to endemic regions.</li>\n<li>Remote, rabies-endemic areas where access to PEP is difficult</li>\n<li>Areas where&nbsp;dog bite incidence is &gt;5% per year</li>\n<li>Areas where vampire bat rabies is known to be present.</li>\n</ul>\n<p>Pre-exposure rabies vaccination consists of <strong>3&nbsp;intramuscular (IM) or 3 intradermal (ID)</strong>&nbsp;doses. These are given on <strong>days 0, 7 and 21 or 28.</strong></p>\n<ul>\n<li>Adults - the vaccine should always be administered in the deltoid area of the arm</li>\n<li>Young children (under 1 year of age)- Administration into the anterolateral area of the thigh is recommended.</li>\n<li><strong>Rabies vaccine </strong>should<strong> never</strong> be administered in the<strong> gluteal area.</strong>&nbsp;Administration in this manner will result in <strong>lower neutralizing antibody titers.</strong></li>\n</ul>\n<p>For exposed or re-exposed patients who can document previous completion of PEP or PrEP the following guidelines would be applicable:</p>\n<ul>\n<li>Proper wound management should be done.</li>\n<li>There is no need for the administration of RIG.</li>\n<li>One site ID or IM vaccine administration on days 0 and 3.</li>\n</ul>\n<p>Only adequate wound washing would be required in case of re-exposure where the animal bite victim has documented proof of complete PEP&nbsp;<strong>within the last three months.</strong></p>\n<p>The following cases are treated as fresh cases and given full PEP:</p>\n<ul>\n<li>Those who have previously received full post-exposure treatment with neural tissue vaccines (NTV) or vaccines of unproven potency</li>\n<li>Those who cannot document complete PEP or PrEP treatment&nbsp;</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB8304",
      "difficulty": "medium"
    },
    {
      "text": "A 7-year-old boy was bitten by a suspected rabid dog . On examination, there are minor scratches and abrasions without bleeding. Which of the following is true about the category and management of the wound?",
      "choices": [
        {
          "id": 1,
          "text": "Category II - Local treatment of wound with povidone and follow up"
        },
        {
          "id": 2,
          "text": "Category III - Local treatment of wound and give ARV and antibiotics"
        },
        {
          "id": 3,
          "text": "Category II - Local treatment of wound and give ARV"
        },
        {
          "id": 4,
          "text": "Category III - Give ARV and anti-rabies immunoglobulin"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Minor scratches and abrasions without bleeding are classified under <strong>category II wounds</strong>. Category II wounds are managed by immediate <strong>local treatment</strong> of wound and vaccination (<strong>ARV</strong>).</p>\n<p>Antibiotics are not required in case of minor scratches and abrasions.</p><p><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;28 September this year will mark the 16th World Rabies Day. This year’s theme ‘Rabies: One Health, Zero Deaths’ will highlight the connection of the environment with both people and animals. Zero by 30 : is the Global strategic plan to end human death from dog mediated rabies by 2030.&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:831,&quot;3&quot;:{&quot;1&quot;:0},&quot;4&quot;:{&quot;1&quot;:2,&quot;2&quot;:16777215},&quot;5&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;6&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;7&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;8&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;11&quot;:4,&quot;12&quot;:0}\">28 September this year will mark the 16th <strong>World Rabies Day</strong>. This year’s theme ‘Rabies: <strong>One Health, Zero Deaths</strong>’ will highlight the connection of the environment with both people and animals. <strong>Zero by 30</strong>: is the Global strategic plan to end human death from dog-mediated rabies by 2030.</span></p><hr><h3>Related Pearl: Rabies vaccines and immunoglobulins schedules</h3><p>According to the Ministry of Health and Family Welfare, Government of India:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f49dfa01d9bd424db725e4ebf600cb98x1280x3397.JPEG\" alt=\"Pearl Image\"><p>WHO category <strong>II</strong> or <strong>III</strong> exposures should receive&nbsp;<strong>post-exposure prophylaxis&nbsp;</strong>(PEP)<strong>&nbsp;immediately.</strong></p>\n<p>One <strong>intradermal&nbsp;</strong>(ID)&nbsp;dose is <strong>0.1 mL</strong> of vaccine and one <strong>intramuscular</strong> (IM) dose is an <strong>entire vial</strong> of vaccine, irrespective of the vial size.</p>\n<p>Should a vaccine dose be delayed for any reason, the PEP schedule should be resumed (not restarted).</p>\n<p><strong>Rabies Immunoglobulin(RIG):&nbsp;</strong></p>\n<ul>\n<li>Passive immunization</li>\n<li><strong>Single-dose</strong>; after initiation of PEP and not beyond 7 days after the first dose of vaccine</li>\n<li>Max dose: <strong>hRIG - 20IU/kg ,&nbsp;</strong><strong>eRIG</strong><strong>&nbsp;- 40IU/kg </strong>body weight</li>\n<li>Vaccines should never be withheld regardless of the availability of RIG.</li>\n<li><strong>Alternatives</strong> for RIG- WHO recommends&nbsp;<strong>m</strong><strong>onoclonal antibodies&nbsp;</strong>(mAb)&nbsp;as a 'cocktail' containing at least <strong>two antibodies</strong> against the rabies virus.</li>\n</ul>\n<p>Administration of RIG:</p>\n<ul>\n<li>RIG should be administered&nbsp;<strong>into</strong> or <strong>around</strong> the <strong>wound site</strong> or sites.</li>\n<li>The&nbsp;<strong>remaining</strong> RIG, if any, should be injected <strong>IM</strong> at a site <strong>distant</strong> from the <strong>site</strong> of vaccine administration.</li>\n<li>RIG may be diluted to a volume sufficient for all wounds to be effectively and safely infiltrated.</li>\n</ul>\n<p>Prioritization&nbsp;of RIG allocation (numbered according to priority order):</p>\n<ol>\n<li>Multiple bites</li>\n<li>Deep wounds</li>\n<li>Bites to head, neck, and hands</li>\n<li>Patients with severe immunodeficiency</li>\n<li>Confirmed/probable rabies in biting animal</li>\n<li>Bites, scratches, and exposure of mucous membranes caused by a bat</li>\n</ol>\n<p><strong>Pre-exposure prophylaxis&nbsp;(PrEP)</strong></p>\n<p>PrEP is considered in the following conditions:</p>\n<ul>\n<li>High-risk groups- laboratory staff, wildlife wardens, veterinarians, animal handlers, and travelers to endemic regions.</li>\n<li>Remote, rabies-endemic areas where access to PEP is difficult</li>\n<li>Areas where&nbsp;dog bite incidence is &gt;5% per year</li>\n<li>Areas where vampire bat rabies is known to be present.</li>\n</ul>\n<p>Pre-exposure rabies vaccination consists of <strong>3&nbsp;intramuscular (IM) or 3 intradermal (ID)</strong>&nbsp;doses. These are given on <strong>days 0, 7 and 21 or 28.</strong></p>\n<ul>\n<li>Adults - the vaccine should always be administered in the deltoid area of the arm</li>\n<li>Young children (under 1 year of age)- Administration into the anterolateral area of the thigh is recommended.</li>\n<li><strong>Rabies vaccine </strong>should<strong> never</strong> be administered in the<strong> gluteal area.</strong>&nbsp;Administration in this manner will result in <strong>lower neutralizing antibody titers.</strong></li>\n</ul>\n<p>For exposed or re-exposed patients who can document previous completion of PEP or PrEP the following guidelines would be applicable:</p>\n<ul>\n<li>Proper wound management should be done.</li>\n<li>There is no need for the administration of RIG.</li>\n<li>One site ID or IM vaccine administration on days 0 and 3.</li>\n</ul>\n<p>Only adequate wound washing would be required in case of re-exposure where the animal bite victim has documented proof of complete PEP&nbsp;<strong>within the last three months.</strong></p>\n<p>The following cases are treated as fresh cases and given full PEP:</p>\n<ul>\n<li>Those who have previously received full post-exposure treatment with neural tissue vaccines (NTV) or vaccines of unproven potency</li>\n<li>Those who cannot document complete PEP or PrEP treatment&nbsp;</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB8305",
      "difficulty": "easy"
    },
    {
      "text": "A public health worker was brought with multiple transdermal dog bites. He tells you that he had received pre-exposure prophylaxis 6 months ago. What is the next best step in management?",
      "choices": [
        {
          "id": 1,
          "text": "Only wound treatment is required"
        },
        {
          "id": 2,
          "text": "Only RIG should be given"
        },
        {
          "id": 3,
          "text": "Wound washing and ARV with half dose of RIG"
        },
        {
          "id": 4,
          "text": "Wound treatment and ARV; RIG is not required"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<div class=\"p-rich_text_section\">This given clinical scenario of a patient with <strong data-stringify-type=\"bold\">multiple transdermal dog bites </strong>would be categorised under category III. As the patient received <strong data-stringify-type=\"bold\">pre-exposure prophylaxis</strong> <strong>6 months ago</strong>, his line of management includes the following:</div>\n<ol class=\"p-rich_text_list p-rich_text_list__ordered\" data-stringify-type=\"ordered-list\" data-indent=\"0\" data-border=\"0\">\n<li data-stringify-indent=\"0\" data-stringify-border=\"0\"><strong data-stringify-type=\"bold\">Wound treatment</strong> with soap and running water for <strong data-stringify-type=\"bold\">15 minutes</strong> and application of antiseptic</li>\n<li data-stringify-indent=\"0\" data-stringify-border=\"0\">Anti-rabies vaccine <strong data-stringify-type=\"bold\">2 doses</strong> on day 0 and day 3, with either intradermal vaccine(0.1ml, 1 site) or intramuscular vaccine(1 vial, 1site).</li>\n</ol>\n<div class=\"p-rich_text_section\">There is no requirement for Rabies Immunoglobulin (RIG), if previous pre-exposure prophylaxis or post exposure prophylaxis documentation is available. If documentation of PEP or PrEP is <strong data-stringify-type=\"bold\">unavailable</strong>, patient should be treated as <strong data-stringify-type=\"bold\">fresh case </strong>and given <strong data-stringify-type=\"bold\">full PEP.</strong></div><hr><h3>Related Pearl: Rabies vaccines and immunoglobulins schedules</h3><p>According to the Ministry of Health and Family Welfare, Government of India:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f49dfa01d9bd424db725e4ebf600cb98x1280x3397.JPEG\" alt=\"Pearl Image\"><p>WHO category <strong>II</strong> or <strong>III</strong> exposures should receive&nbsp;<strong>post-exposure prophylaxis&nbsp;</strong>(PEP)<strong>&nbsp;immediately.</strong></p>\n<p>One <strong>intradermal&nbsp;</strong>(ID)&nbsp;dose is <strong>0.1 mL</strong> of vaccine and one <strong>intramuscular</strong> (IM) dose is an <strong>entire vial</strong> of vaccine, irrespective of the vial size.</p>\n<p>Should a vaccine dose be delayed for any reason, the PEP schedule should be resumed (not restarted).</p>\n<p><strong>Rabies Immunoglobulin(RIG):&nbsp;</strong></p>\n<ul>\n<li>Passive immunization</li>\n<li><strong>Single-dose</strong>; after initiation of PEP and not beyond 7 days after the first dose of vaccine</li>\n<li>Max dose: <strong>hRIG - 20IU/kg ,&nbsp;</strong><strong>eRIG</strong><strong>&nbsp;- 40IU/kg </strong>body weight</li>\n<li>Vaccines should never be withheld regardless of the availability of RIG.</li>\n<li><strong>Alternatives</strong> for RIG- WHO recommends&nbsp;<strong>m</strong><strong>onoclonal antibodies&nbsp;</strong>(mAb)&nbsp;as a 'cocktail' containing at least <strong>two antibodies</strong> against the rabies virus.</li>\n</ul>\n<p>Administration of RIG:</p>\n<ul>\n<li>RIG should be administered&nbsp;<strong>into</strong> or <strong>around</strong> the <strong>wound site</strong> or sites.</li>\n<li>The&nbsp;<strong>remaining</strong> RIG, if any, should be injected <strong>IM</strong> at a site <strong>distant</strong> from the <strong>site</strong> of vaccine administration.</li>\n<li>RIG may be diluted to a volume sufficient for all wounds to be effectively and safely infiltrated.</li>\n</ul>\n<p>Prioritization&nbsp;of RIG allocation (numbered according to priority order):</p>\n<ol>\n<li>Multiple bites</li>\n<li>Deep wounds</li>\n<li>Bites to head, neck, and hands</li>\n<li>Patients with severe immunodeficiency</li>\n<li>Confirmed/probable rabies in biting animal</li>\n<li>Bites, scratches, and exposure of mucous membranes caused by a bat</li>\n</ol>\n<p><strong>Pre-exposure prophylaxis&nbsp;(PrEP)</strong></p>\n<p>PrEP is considered in the following conditions:</p>\n<ul>\n<li>High-risk groups- laboratory staff, wildlife wardens, veterinarians, animal handlers, and travelers to endemic regions.</li>\n<li>Remote, rabies-endemic areas where access to PEP is difficult</li>\n<li>Areas where&nbsp;dog bite incidence is &gt;5% per year</li>\n<li>Areas where vampire bat rabies is known to be present.</li>\n</ul>\n<p>Pre-exposure rabies vaccination consists of <strong>3&nbsp;intramuscular (IM) or 3 intradermal (ID)</strong>&nbsp;doses. These are given on <strong>days 0, 7 and 21 or 28.</strong></p>\n<ul>\n<li>Adults - the vaccine should always be administered in the deltoid area of the arm</li>\n<li>Young children (under 1 year of age)- Administration into the anterolateral area of the thigh is recommended.</li>\n<li><strong>Rabies vaccine </strong>should<strong> never</strong> be administered in the<strong> gluteal area.</strong>&nbsp;Administration in this manner will result in <strong>lower neutralizing antibody titers.</strong></li>\n</ul>\n<p>For exposed or re-exposed patients who can document previous completion of PEP or PrEP the following guidelines would be applicable:</p>\n<ul>\n<li>Proper wound management should be done.</li>\n<li>There is no need for the administration of RIG.</li>\n<li>One site ID or IM vaccine administration on days 0 and 3.</li>\n</ul>\n<p>Only adequate wound washing would be required in case of re-exposure where the animal bite victim has documented proof of complete PEP&nbsp;<strong>within the last three months.</strong></p>\n<p>The following cases are treated as fresh cases and given full PEP:</p>\n<ul>\n<li>Those who have previously received full post-exposure treatment with neural tissue vaccines (NTV) or vaccines of unproven potency</li>\n<li>Those who cannot document complete PEP or PrEP treatment&nbsp;</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7168",
      "difficulty": "medium"
    },
    {
      "text": "An​ 8-year-old child was brought with an unprovoked dog bite. Which of the following measures should be taken?",
      "choices": [
        {
          "id": 1,
          "text": "Withhold the vaccine and observe the dog for 10 days"
        },
        {
          "id": 2,
          "text": "Give half the dose of the vaccine"
        },
        {
          "id": 3,
          "text": "Give antibiotics only"
        },
        {
          "id": 4,
          "text": "Give cell culture derived vaccine"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>This child should be given immediate post-exposure prophylaxis (<strong>PEP</strong>)&nbsp;by administering a <strong>cell culture-derived vaccine</strong>&nbsp;to reduce the chances of getting rabies.</p><p><strong>Zero by 30&nbsp;</strong>is the global strategic plan to end human death from dog-mediated rabies by <strong>2030</strong>.</p><hr><h3>Related Pearl: Rabies vaccines and immunoglobulins schedules</h3><p>According to the Ministry of Health and Family Welfare, Government of India:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f49dfa01d9bd424db725e4ebf600cb98x1280x3397.JPEG\" alt=\"Pearl Image\"><p>WHO category <strong>II</strong> or <strong>III</strong> exposures should receive&nbsp;<strong>post-exposure prophylaxis&nbsp;</strong>(PEP)<strong>&nbsp;immediately.</strong></p>\n<p>One <strong>intradermal&nbsp;</strong>(ID)&nbsp;dose is <strong>0.1 mL</strong> of vaccine and one <strong>intramuscular</strong> (IM) dose is an <strong>entire vial</strong> of vaccine, irrespective of the vial size.</p>\n<p>Should a vaccine dose be delayed for any reason, the PEP schedule should be resumed (not restarted).</p>\n<p><strong>Rabies Immunoglobulin(RIG):&nbsp;</strong></p>\n<ul>\n<li>Passive immunization</li>\n<li><strong>Single-dose</strong>; after initiation of PEP and not beyond 7 days after the first dose of vaccine</li>\n<li>Max dose: <strong>hRIG - 20IU/kg ,&nbsp;</strong><strong>eRIG</strong><strong>&nbsp;- 40IU/kg </strong>body weight</li>\n<li>Vaccines should never be withheld regardless of the availability of RIG.</li>\n<li><strong>Alternatives</strong> for RIG- WHO recommends&nbsp;<strong>m</strong><strong>onoclonal antibodies&nbsp;</strong>(mAb)&nbsp;as a 'cocktail' containing at least <strong>two antibodies</strong> against the rabies virus.</li>\n</ul>\n<p>Administration of RIG:</p>\n<ul>\n<li>RIG should be administered&nbsp;<strong>into</strong> or <strong>around</strong> the <strong>wound site</strong> or sites.</li>\n<li>The&nbsp;<strong>remaining</strong> RIG, if any, should be injected <strong>IM</strong> at a site <strong>distant</strong> from the <strong>site</strong> of vaccine administration.</li>\n<li>RIG may be diluted to a volume sufficient for all wounds to be effectively and safely infiltrated.</li>\n</ul>\n<p>Prioritization&nbsp;of RIG allocation (numbered according to priority order):</p>\n<ol>\n<li>Multiple bites</li>\n<li>Deep wounds</li>\n<li>Bites to head, neck, and hands</li>\n<li>Patients with severe immunodeficiency</li>\n<li>Confirmed/probable rabies in biting animal</li>\n<li>Bites, scratches, and exposure of mucous membranes caused by a bat</li>\n</ol>\n<p><strong>Pre-exposure prophylaxis&nbsp;(PrEP)</strong></p>\n<p>PrEP is considered in the following conditions:</p>\n<ul>\n<li>High-risk groups- laboratory staff, wildlife wardens, veterinarians, animal handlers, and travelers to endemic regions.</li>\n<li>Remote, rabies-endemic areas where access to PEP is difficult</li>\n<li>Areas where&nbsp;dog bite incidence is &gt;5% per year</li>\n<li>Areas where vampire bat rabies is known to be present.</li>\n</ul>\n<p>Pre-exposure rabies vaccination consists of <strong>3&nbsp;intramuscular (IM) or 3 intradermal (ID)</strong>&nbsp;doses. These are given on <strong>days 0, 7 and 21 or 28.</strong></p>\n<ul>\n<li>Adults - the vaccine should always be administered in the deltoid area of the arm</li>\n<li>Young children (under 1 year of age)- Administration into the anterolateral area of the thigh is recommended.</li>\n<li><strong>Rabies vaccine </strong>should<strong> never</strong> be administered in the<strong> gluteal area.</strong>&nbsp;Administration in this manner will result in <strong>lower neutralizing antibody titers.</strong></li>\n</ul>\n<p>For exposed or re-exposed patients who can document previous completion of PEP or PrEP the following guidelines would be applicable:</p>\n<ul>\n<li>Proper wound management should be done.</li>\n<li>There is no need for the administration of RIG.</li>\n<li>One site ID or IM vaccine administration on days 0 and 3.</li>\n</ul>\n<p>Only adequate wound washing would be required in case of re-exposure where the animal bite victim has documented proof of complete PEP&nbsp;<strong>within the last three months.</strong></p>\n<p>The following cases are treated as fresh cases and given full PEP:</p>\n<ul>\n<li>Those who have previously received full post-exposure treatment with neural tissue vaccines (NTV) or vaccines of unproven potency</li>\n<li>Those who cannot document complete PEP or PrEP treatment&nbsp;</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB8307",
      "difficulty": "medium"
    },
    {
      "text": "A 5-year-old boy had received a full course rabies vaccine taken in December 2018. His pet dog which has been fully vaccinated now (November 2019) bit him on the toe. Bleeding was present at the site of the bite. What would be the line of treatment?",
      "choices": [
        {
          "id": 1,
          "text": "No treatment"
        },
        {
          "id": 2,
          "text": "2 doses of vaccine on Day 0 & 3"
        },
        {
          "id": 3,
          "text": "5 doses of vaccine with Immunoglobulin"
        },
        {
          "id": 4,
          "text": "5 doses of vaccine"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>This boy should receive<strong> 2 doses </strong>of vaccine on<strong> days 0 &amp; 3</strong> as he has received a prior course of post-exposure prophylaxis (<strong>PEP</strong>) <strong>&gt; 3 months ago</strong>.</p>\n<p>Management of a new dog bite in a <strong>previously immunized </strong>individual with either pre-exposure prophylaxis (PrEP) or post-exposure prophylaxis (PEP) is as follows:</p>\n<ul>\n<li>Category I: Wound treatment only</li>\n<li>Category II/ III:\n<ul>\n<li><strong>Wound treatment</strong> with soap and running water for 15 min and apply antiseptic</li>\n<li>Receive <strong>Anti-rabies vaccine (ARV)</strong> <strong>2 doses ID</strong> (0.1 ml, 1 site)/ <strong>2 doses IM</strong> (1 VIAL, 1 site) on days <strong>0 and 3.</strong></li>\n</ul>\n</li>\n</ul>\n<p>*Note: In developing countries like India, the vaccination status of animals alone, doesn't play a <strong>significant</strong> role in <strong>determining</strong> the initiation of prophylaxis in humans.</p><hr><h3>Related Pearl: Rabies vaccines and immunoglobulins schedules</h3><p>According to the Ministry of Health and Family Welfare, Government of India:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f49dfa01d9bd424db725e4ebf600cb98x1280x3397.JPEG\" alt=\"Pearl Image\"><p>WHO category <strong>II</strong> or <strong>III</strong> exposures should receive&nbsp;<strong>post-exposure prophylaxis&nbsp;</strong>(PEP)<strong>&nbsp;immediately.</strong></p>\n<p>One <strong>intradermal&nbsp;</strong>(ID)&nbsp;dose is <strong>0.1 mL</strong> of vaccine and one <strong>intramuscular</strong> (IM) dose is an <strong>entire vial</strong> of vaccine, irrespective of the vial size.</p>\n<p>Should a vaccine dose be delayed for any reason, the PEP schedule should be resumed (not restarted).</p>\n<p><strong>Rabies Immunoglobulin(RIG):&nbsp;</strong></p>\n<ul>\n<li>Passive immunization</li>\n<li><strong>Single-dose</strong>; after initiation of PEP and not beyond 7 days after the first dose of vaccine</li>\n<li>Max dose: <strong>hRIG - 20IU/kg ,&nbsp;</strong><strong>eRIG</strong><strong>&nbsp;- 40IU/kg </strong>body weight</li>\n<li>Vaccines should never be withheld regardless of the availability of RIG.</li>\n<li><strong>Alternatives</strong> for RIG- WHO recommends&nbsp;<strong>m</strong><strong>onoclonal antibodies&nbsp;</strong>(mAb)&nbsp;as a 'cocktail' containing at least <strong>two antibodies</strong> against the rabies virus.</li>\n</ul>\n<p>Administration of RIG:</p>\n<ul>\n<li>RIG should be administered&nbsp;<strong>into</strong> or <strong>around</strong> the <strong>wound site</strong> or sites.</li>\n<li>The&nbsp;<strong>remaining</strong> RIG, if any, should be injected <strong>IM</strong> at a site <strong>distant</strong> from the <strong>site</strong> of vaccine administration.</li>\n<li>RIG may be diluted to a volume sufficient for all wounds to be effectively and safely infiltrated.</li>\n</ul>\n<p>Prioritization&nbsp;of RIG allocation (numbered according to priority order):</p>\n<ol>\n<li>Multiple bites</li>\n<li>Deep wounds</li>\n<li>Bites to head, neck, and hands</li>\n<li>Patients with severe immunodeficiency</li>\n<li>Confirmed/probable rabies in biting animal</li>\n<li>Bites, scratches, and exposure of mucous membranes caused by a bat</li>\n</ol>\n<p><strong>Pre-exposure prophylaxis&nbsp;(PrEP)</strong></p>\n<p>PrEP is considered in the following conditions:</p>\n<ul>\n<li>High-risk groups- laboratory staff, wildlife wardens, veterinarians, animal handlers, and travelers to endemic regions.</li>\n<li>Remote, rabies-endemic areas where access to PEP is difficult</li>\n<li>Areas where&nbsp;dog bite incidence is &gt;5% per year</li>\n<li>Areas where vampire bat rabies is known to be present.</li>\n</ul>\n<p>Pre-exposure rabies vaccination consists of <strong>3&nbsp;intramuscular (IM) or 3 intradermal (ID)</strong>&nbsp;doses. These are given on <strong>days 0, 7 and 21 or 28.</strong></p>\n<ul>\n<li>Adults - the vaccine should always be administered in the deltoid area of the arm</li>\n<li>Young children (under 1 year of age)- Administration into the anterolateral area of the thigh is recommended.</li>\n<li><strong>Rabies vaccine </strong>should<strong> never</strong> be administered in the<strong> gluteal area.</strong>&nbsp;Administration in this manner will result in <strong>lower neutralizing antibody titers.</strong></li>\n</ul>\n<p>For exposed or re-exposed patients who can document previous completion of PEP or PrEP the following guidelines would be applicable:</p>\n<ul>\n<li>Proper wound management should be done.</li>\n<li>There is no need for the administration of RIG.</li>\n<li>One site ID or IM vaccine administration on days 0 and 3.</li>\n</ul>\n<p>Only adequate wound washing would be required in case of re-exposure where the animal bite victim has documented proof of complete PEP&nbsp;<strong>within the last three months.</strong></p>\n<p>The following cases are treated as fresh cases and given full PEP:</p>\n<ul>\n<li>Those who have previously received full post-exposure treatment with neural tissue vaccines (NTV) or vaccines of unproven potency</li>\n<li>Those who cannot document complete PEP or PrEP treatment&nbsp;</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0180",
      "difficulty": "medium"
    },
    {
      "text": "What is the incubation period of yellow fever?",
      "choices": [
        {
          "id": 1,
          "text": "3-6 days"
        },
        {
          "id": 2,
          "text": "3-4 weeks"
        },
        {
          "id": 3,
          "text": "1-2 weeks"
        },
        {
          "id": 4,
          "text": "8-10 weeks"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The incubation period of yellow fever is <strong>3&ndash;6 days</strong>.</p><hr><h3>Related Pearl: Diseases with usual incubation period</h3><table>\n<tbody>\n<tr>\n<td><strong>Disease</strong></td>\n<td><strong>Incubation period(days)</strong></td>\n</tr>\n<tr>\n<td>Dengue</td>\n<td>5-8</td>\n</tr>\n<tr>\n<td>Typhoid</td>\n<td>10-14</td>\n</tr>\n<tr>\n<td>Herpes simplex</td>\n<td>5-8</td>\n</tr>\n<tr>\n<td>Enterovirus disease</td>\n<td>6-12</td>\n</tr>\n<tr>\n<td>Poliomyelitis</td>\n<td>5-20</td>\n</tr>\n<tr>\n<td>Measles</td>\n<td>9-12</td>\n</tr>\n<tr>\n<td>Smallpox</td>\n<td>12-14</td>\n</tr>\n<tr>\n<td>Chickenpox</td>\n<td>13-17</td>\n</tr>\n<tr>\n<td>Mumps</td>\n<td>16-20</td>\n</tr>\n<tr>\n<td>Rubella</td>\n<td>17-20</td>\n</tr>\n<tr>\n<td>Mononucleosis</td>\n<td>30-50</td>\n</tr>\n<tr>\n<td>Hepatitis A</td>\n<td>15-40</td>\n</tr>\n<tr>\n<td>Hepatitis B &amp; C</td>\n<td>50-150</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB8308",
      "difficulty": "medium"
    },
    {
      "text": "According to the International Health Regulations, an Aedes aegypti index of which of the following must be maintained to achieve zero risk of spread of yellow fever?",
      "choices": [
        {
          "id": 1,
          "text": "< 1%"
        },
        {
          "id": 2,
          "text": "< 5%"
        },
        {
          "id": 3,
          "text": "< 0.5%"
        },
        {
          "id": 4,
          "text": "< 0.1%"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The <strong><em>Aedes aegypti</em> index</strong> should be <strong>&lt; 1%</strong> in endemic areas to achieve <strong>zero risk</strong> of spread of <strong>yellow fever</strong>.</p>\n<p>The <em>Aedes aegypti</em> index is a type of house index. It refers to the percentage of houses and premises in a limited well-defined area with actual <strong>breeding</strong> of <em>Aedes aegypti</em> <strong>larvae</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB8309",
      "difficulty": "medium"
    },
    {
      "text": "A woman is planning a trip to Morocco, which is endemic for yellow fever. As per travel regulations, she receives the yellow fever vaccine. After how many days following vaccination is she eligible to travel?",
      "choices": [
        {
          "id": 1,
          "text": "5"
        },
        {
          "id": 2,
          "text": "10"
        },
        {
          "id": 3,
          "text": "15"
        },
        {
          "id": 4,
          "text": "7"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>This woman is eligible to travel to the endemic area <strong>10 days</strong> after being <strong>vaccinated</strong> for <strong>yellow fever</strong>. This period is required for the majority of vaccine recipients to <strong>develop immunity</strong>.</p>\n<p>The&nbsp;<strong>17D vaccine</strong>&nbsp;for yellow fever is given <strong>subcutaneously</strong>. Unvaccinated people are required to remain&nbsp;<strong>quarantined </strong>for<strong> 6 days&nbsp;</strong>(maximum period of incubation).</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB8310",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is the yellow fever reference center in India?",
      "choices": [
        {
          "id": 1,
          "text": "Halfkin’s institute"
        },
        {
          "id": 2,
          "text": "Central Research institute, Kasauli"
        },
        {
          "id": 3,
          "text": "National Institute of Nutrition,  Hyderabad"
        },
        {
          "id": 4,
          "text": "AIIMS, Delhi"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The <strong>reference centers</strong> for <strong>yellow fever</strong> in India are as follows:</p>\n<ul>\n<li>Central Research Institute, <strong>Kasauli</strong></li>\n<li>National Institute of Virology, <strong>Pune</strong></li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB8311",
      "difficulty": "medium"
    },
    {
      "text": "An outbreak of Kyasanur forest disease occurred among a group of forest officers in Karnataka. Which of the following vectors should be targeted to prevent the further spread of the disease?",
      "choices": [
        {
          "id": 1,
          "text": "Sand fly"
        },
        {
          "id": 2,
          "text": "Tick"
        },
        {
          "id": 3,
          "text": "Mosquito"
        },
        {
          "id": 4,
          "text": "Mite"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Kyasanur forest disease</strong> (KFD) is transmitted by the bite of infective <strong>hard ticks</strong>&nbsp;of<strong>&nbsp;<em>Haemaphysalis </em></strong>species. Hence, control of ticks must be done to prevent spread of the disease.</p>\n<p>KFD is a hemorrhagic febrile disease caused by a&nbsp;<strong>flavivirus</strong>. Man is an&nbsp;incidental dead-end host in the life cycle of the vector (hard tick). Small mammals like <strong>rodents </strong>and<strong> squirrels</strong> are the <strong>reservoirs</strong> while <strong>monkeys</strong> serve as the <strong>amplifier</strong> hosts. KFD is endemic in 4 districts of <strong>Karnataka</strong> (Shimoga, North Kannada, South Kannada, Chikmagalur).</p>\n<p>The <strong>incubation</strong> period is between<strong> 3 to 8</strong> <strong>days</strong>. The disease presents with sudden onset of fever, headache, myalgia. In severe cases, gastrointestinal disturbances and hemorrhages from the nose, gums, stomach, and intestine may occur. The case fatality rate is 5 to 10%.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB8312",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following organisms follow a bird-arthropod-human transmission route?",
      "choices": [
        {
          "id": 1,
          "text": "Malaria"
        },
        {
          "id": 2,
          "text": "Japanese encephalitis"
        },
        {
          "id": 3,
          "text": "Plague"
        },
        {
          "id": 4,
          "text": "Paragonimiasis"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Japanese encephalitis follows bird-arthropod-human transmission.</p>\n<p>JE virus infects several extra-human hosts, e.g., pigs and birds (like pond herons).&nbsp; The basic cycles of transmission are:</p>\n<p>&nbsp;(a)Pig &rarr; Mosquito&nbsp; &rarr; Pig</p>\n<p>(b) Bird&nbsp;&rarr; Mosquito&nbsp;&rarr; Bird</p>\n<p>Humans are incidental \"dead-end\" hosts and are infected by the bite of infected Culex mosquitoes.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7460",
      "difficulty": "easy"
    },
    {
      "text": "Which following is false about Japanese encephalitis?",
      "choices": [
        {
          "id": 1,
          "text": "Man is the incidental dead-end host"
        },
        {
          "id": 2,
          "text": "Culicines act as vectors for this condition"
        },
        {
          "id": 3,
          "text": "The incubation period is 1-2 days"
        },
        {
          "id": 4,
          "text": "It is caused by a group B arbovirus"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The <strong>incubation period</strong> of Japanese&nbsp;encephalitis (<strong>JE</strong>) in man following a mosquito bite is&nbsp;<strong>5-15 days</strong>.</p>\n<p>JE is mosquito-borne encephalitis caused by a <strong>group B arbovirus</strong> (Flavivirus). It is transmitted by <em><strong>Culex</strong></em>&nbsp;(culicine) mosquitoes mainly <em>C.tritaeniorhynchus</em> and <em>C.vishnui.</em> <strong>Ardeid birds&nbsp;</strong>(herons) are the reservoirs while <strong>pigs</strong> are the amplifier hosts. Man is an incidental dead-end host. Man-to-man transmission has not been recorded.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB8314",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is true about Japanese encephalitis?",
      "choices": [
        {
          "id": 1,
          "text": "SA-14-14-2 strain vaccine is commonly used"
        },
        {
          "id": 2,
          "text": "Diagnosis is confirmed by CSF culture"
        },
        {
          "id": 3,
          "text": "Patients usually recover without any sequelae"
        },
        {
          "id": 4,
          "text": "Subclinical infection does not occur"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>SA-14-14-2 strain vaccine</strong> is used for the prevention of Japanese encephalitis (<strong>JE</strong>).</p>\n<p>Japanese encephalitis (JE) is mosquito-borne encephalitis caused by a group B arbovirus (Flavivirus) and transmitted by <em>Culex</em> mosquitoes. <strong>Most</strong> <strong>individuals</strong> develop <strong>subclinical infection</strong>. </p>\n<p>The course of disease in man divided into 3 stages:</p>\n<ul>\n<li><strong>Prodromal stage</strong> - fever, headache, gastrointestinal disturbances, lethargy, and malaise</li>\n<li><strong>Acute encephalitic </strong>stage - high-grade fever, nuchal rigidity, convulsions, signs of raised intracranial pressure, paralysis, altered sensorium </li>\n<li><strong>Late-stage </strong>and sequelae -  neurological or psychiatric <strong>sequelae</strong> seen in up to <strong>50%</strong> of survivors</li>\n</ul>\n<p>Diagnosis is <strong>serological</strong>, using blood or CSF samples. The virus rarely grows in culture. The case fatality rate varies between 20-40%. There are 3 types of JE vaccines available:</p>\n<ul>\n<li>Nakayama or Beijing strain - purified inactivated vaccine</li>\n<li>Beijing P-3 strain - inactivated vaccine</li>\n<li>SA-14-14-2 - live attenuated vaccine</li>\n</ul>\n<p><strong>Note</strong>: Killed JE vaccines (Inactivated SA 14-14-2 cell culture-derived and inactivated Vero cell culture-derived) are <strong>gradually</strong> <strong>replacing</strong> live attenuated vaccines.  According to the national immunisation schedule, both live attenuated, killed-inactivated vaccines are now used for vaccination against the JE virus.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB8317",
      "difficulty": "easy"
    },
    {
      "text": "The life cycle of which of the following is depicted in the image below?",
      "choices": [
        {
          "id": 1,
          "text": "Japanese encephalitis"
        },
        {
          "id": 2,
          "text": "Zika virus"
        },
        {
          "id": 3,
          "text": "Rabies"
        },
        {
          "id": 4,
          "text": "Nipah virus"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The given image depicts the life cycle of the <strong>Nipah virus</strong>.</p>\n<p>Nipah virus&nbsp;is an <strong>RNA</strong> virus that belongs to the family&nbsp;<strong>Paramyxoviridae</strong>, genus Henipavirus.&nbsp;It is a zoonotic virus that shows both animal-to-human (bats, pigs) and human-to-human transmission. The natural hosts are&nbsp;<strong>fruit bats</strong>&nbsp;of the Pteropodidae family.</p>\n<p>The clinical manifestations include asymptomatic subclinical&nbsp;infection, acute respiratory infection, and fatal encephalitis.&nbsp;There is <strong>no treatment</strong> or vaccine available for either people or animals. The primary treatment for humans is <strong>supportive</strong> care.</p>\n<p>Nipah virus is on the WHO list of <strong>Blueprint priority diseases</strong>.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/4bd6f0572d234ff7a7a1547f3143977c.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC6999",
      "difficulty": "medium"
    }
  ]
}